Next Article in Journal
Discrimination of Trichosanthis Fructus from Different Geographical Origins Using Near Infrared Spectroscopy Coupled with Chemometric Techniques
Next Article in Special Issue
Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
Previous Article in Journal
A Water-Soluble Microencapsulated Milk Thistle Extract as Active Ingredient for Dermal Formulations
Previous Article in Special Issue
Size-Dependent Biological Effects of Quercetin Nanocrystals
Article Menu
Issue 8 (April-2) cover image

Export Article

Open AccessArticle

Diamond Nanoparticles Downregulate Expression of CycD and CycE in Glioma Cells

1
Division of Nanobiotechnology, Faculty of Animal Sciences, Warsaw University of Life Sciences, Ciszewskiego 8, 02-786 Warsaw, Poland
2
Department of Neurosurgery, Oncology Center- Maria Sklodowska Curie Memorial, Warsaw, Roentgena 5, 02-781 Warsaw, Poland
3
Laboratory of Epidemiology, Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland
4
Department of Veterinary and Animal Sciences, University of Copenhagen, Groennegaardsvej 3, 1870 Frederiksberg, Denmark
*
Author to whom correspondence should be addressed.
Molecules 2019, 24(8), 1549; https://doi.org/10.3390/molecules24081549
Received: 19 March 2019 / Revised: 15 April 2019 / Accepted: 17 April 2019 / Published: 19 April 2019
(This article belongs to the Special Issue Nanomaterials for Cancer Diagnosis and Therapy)
  |  
PDF [4599 KB, uploaded 19 April 2019]
  |     |  

Abstract

Our previous studies have shown that diamond nanoparticles (NDs) exhibited antiangiogenic and proapoptotic properties in vitro in glioblastoma multiforme (GBM) cells and in tumors in vivo. Moreover, NDs inhibited adhesion, leading to the suppression of migration and invasion of GBM. In the present study, we hypothesized that the NDs might also inhibit proliferation and cell cycle in glioma cells. Experiments were performed in vitro with the U87 and U118 lines of GBM cells, and for comparison, the Hs5 line of stromal cells (normal cells) after 24 h and 72 h of treatment. The analyses included cell morphology, cell death, viability, and cell cycle analysis, double timing assay, and gene expression (Rb, E2F1, CycA, CycB, CycD, CycE, PTEN, Ki-67). After 72 h of ND treatment, the expression level of Rb, CycD, and CycE in the U118 cells, and E2F1, CycD, and CycE in the U87 cells were significantly lower in comparison to those in the control group. We observed that decreased expression of cyclins inhibited the G1/S phase transition, arresting the cell cycle in the G0/G1 phase in glioma cells. The NDs did not affect the cell cycle as well as PTEN and Ki-67 expression in normal cells (Hs5), although it can be assumed that the NDs reduced proliferation and altered the cell cycle in fast dividing cells. View Full-Text
Keywords: diamond nanoparticles; glioblastoma; proliferation; cell cycle; cancer diamond nanoparticles; glioblastoma; proliferation; cell cycle; cancer
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Grodzik, M.; Szczepaniak, J.; Strojny-Cieslak, B.; Hotowy, A.; Wierzbicki, M.; Jaworski, S.; Kutwin, M.; Soltan, E.; Mandat, T.; Lewicka, A.; Chwalibog, A. Diamond Nanoparticles Downregulate Expression of CycD and CycE in Glioma Cells. Molecules 2019, 24, 1549.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top